SILINI, ENRICO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.218
AS - Asia 1.895
EU - Europa 1.466
SA - Sud America 235
AF - Africa 53
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 5.875
Nazione #
US - Stati Uniti d'America 2.167
CN - Cina 1.014
SG - Singapore 367
IE - Irlanda 342
DE - Germania 211
UA - Ucraina 205
FI - Finlandia 183
HK - Hong Kong 179
BR - Brasile 178
VN - Vietnam 152
RU - Federazione Russa 146
FR - Francia 100
SE - Svezia 84
GB - Regno Unito 76
IT - Italia 57
IN - India 37
JP - Giappone 32
CA - Canada 31
IQ - Iraq 18
BD - Bangladesh 17
AR - Argentina 16
MX - Messico 15
ZA - Sudafrica 15
PL - Polonia 13
CZ - Repubblica Ceca 10
UZ - Uzbekistan 10
VE - Venezuela 10
ID - Indonesia 9
MA - Marocco 8
SA - Arabia Saudita 8
CO - Colombia 7
EC - Ecuador 7
CL - Cile 6
LT - Lituania 6
PK - Pakistan 6
TR - Turchia 6
BE - Belgio 5
NL - Olanda 5
PH - Filippine 5
PY - Paraguay 5
ES - Italia 4
KE - Kenya 4
MY - Malesia 4
TN - Tunisia 4
AT - Austria 3
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
IL - Israele 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
CH - Svizzera 2
IR - Iran 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 5.875
Città #
Dublin 342
Chandler 335
Jacksonville 296
Nanjing 239
Ashburn 201
Beijing 180
Hong Kong 177
San Jose 176
Singapore 172
Dallas 124
Boardman 99
Nanchang 88
Princeton 69
Hebei 68
Lawrence 63
Lauterbourg 61
Shenyang 60
Wilmington 59
Jiaxing 51
Changsha 50
Munich 50
Los Angeles 48
Tianjin 48
Hanoi 41
Ho Chi Minh City 40
Hangzhou 39
Medford 37
Moscow 34
Helsinki 33
Tokyo 31
Buffalo 25
Orem 25
Milan 24
Ann Arbor 23
Shanghai 23
New York 22
Redondo Beach 21
Turku 19
Verona 17
Norwalk 15
São Paulo 15
Toronto 15
Frankfurt am Main 14
Brooklyn 13
Johannesburg 12
Warsaw 12
Woodbridge 12
Jinan 10
Tashkent 10
Baghdad 9
Haiphong 9
Kunming 9
Santa Clara 9
Brno 8
Chennai 8
Des Moines 8
Montreal 8
Stockholm 8
Auburn Hills 7
Guangzhou 7
The Dalles 7
Biên Hòa 6
Boston 6
Dearborn 6
Dong Ket 6
Manchester 6
Mexico City 6
Phoenix 6
Zhengzhou 6
Brussels 5
Chicago 5
Da Nang 5
London 5
San Francisco 5
Seattle 5
Agadir 4
Atlanta 4
Buenos Aires 4
Curitiba 4
Falkenstein 4
Falls Church 4
Mumbai 4
Nairobi 4
Rio de Janeiro 4
Addis Ababa 3
Amsterdam 3
Asunción 3
Baku 3
Berlin 3
Bexley 3
Cardiff 3
Changchun 3
Charlotte 3
Columbus 3
Dhaka 3
Hòa Bình 3
Istanbul 3
Kuala Lumpur 3
Lahore 3
Libreville 3
Totale 3.897
Nome #
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 138
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 133
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 128
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 127
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 122
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 118
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 117
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 115
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 113
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 110
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 109
Su di uno "strano" epatocarcinoma 109
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 109
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 107
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 107
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 105
Comparative evaluation of two serologic typing methods of hepatitis C virus 103
Clinical significance of hepatitis C virus genotypes. 102
Association between class II allelles and protection or susceptibility to chronic hepatitis C 100
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 100
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 99
Comparative evaluation of two serological typing methods for hepatitis C virus 99
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 99
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 98
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 96
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 95
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 95
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 94
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 93
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 92
HCV viremia in hemodialysis patients 90
Virological feaures of hepatitis C virus infection in hemodialysis patients 89
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 89
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 88
Different spectrum of liver disease in patients with HCV genotype II and III infection 88
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 87
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 87
Comparative evaluation of HCV core genotyping and serotyping 86
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 83
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 83
HLA genes and chronic hepatitis C severity 83
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 83
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 82
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 82
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 80
Virological features of HCV infection in hemodialysis patients 80
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 79
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 79
Hepatitis C virus core serotypes in haemodialysis patients 75
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 73
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 72
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 71
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 70
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 69
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 68
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 66
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 63
HVR1 variation, viral type and ALT values in chronic HCV infection 63
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 63
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 62
Vertical trasnmission of hepatitis C 61
Molecular epidemiology of HCV infection in drug addicts 61
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 61
Significance of hepatitis C virus genotypes 59
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 52
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 50
null 30
Totale 5.939
Categoria #
all - tutte 23.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 65 48 17
2021/2022234 0 1 12 3 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024266 23 55 6 32 27 57 1 23 1 6 9 26
2024/2025797 30 76 40 28 2 18 34 43 197 17 127 185
2025/20261.829 168 212 188 209 241 89 350 53 209 110 0 0
Totale 5.939